Lindbrook Capital LLC Boosts Stock Holdings in Aflac Incorporated (NYSE:AFL)

Lindbrook Capital LLC boosted its stake in shares of Aflac Incorporated (NYSE:AFL) by 39.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,489 shares of the financial services provider’s stock after purchasing an additional 418 shares during the period. Lindbrook Capital LLC’s holdings in Aflac were worth $123,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Flputnam Investment Management Co. raised its position in shares of Aflac by 0.5% during the 4th quarter. Flputnam Investment Management Co. now owns 25,031 shares of the financial services provider’s stock valued at $2,065,000 after purchasing an additional 122 shares during the period. Baystate Wealth Management LLC increased its stake in Aflac by 24.1% in the 3rd quarter. Baystate Wealth Management LLC now owns 675 shares of the financial services provider’s stock worth $52,000 after buying an additional 131 shares during the period. Dominguez Wealth Management Solutions Inc. increased its stake in Aflac by 0.5% in the 3rd quarter. Dominguez Wealth Management Solutions Inc. now owns 24,969 shares of the financial services provider’s stock worth $1,916,000 after buying an additional 132 shares during the period. Brighton Jones LLC grew its holdings in Aflac by 2.3% during the 3rd quarter. Brighton Jones LLC now owns 6,156 shares of the financial services provider’s stock worth $472,000 after acquiring an additional 136 shares in the last quarter. Finally, MV Capital Management Inc. grew its holdings in Aflac by 3.7% during the 3rd quarter. MV Capital Management Inc. now owns 3,779 shares of the financial services provider’s stock worth $290,000 after acquiring an additional 136 shares in the last quarter. Institutional investors own 67.44% of the company’s stock.

Aflac Price Performance

Shares of AFL opened at $83.75 on Wednesday. The firm has a market cap of $48.19 billion, a price-to-earnings ratio of 10.81, a PEG ratio of 2.28 and a beta of 0.91. The stock has a 50 day moving average of $82.43 and a 200-day moving average of $81.68. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.33. Aflac Incorporated has a 52 week low of $64.10 and a 52 week high of $86.26.

Aflac (NYSE:AFL) last issued its earnings results on Thursday, February 1st. The financial services provider reported $1.25 EPS for the quarter, missing the consensus estimate of $1.47 by ($0.22). The firm had revenue of $3.78 billion during the quarter, compared to analyst estimates of $4.44 billion. Aflac had a return on equity of 17.59% and a net margin of 24.92%. During the same quarter in the previous year, the business posted $1.29 EPS. As a group, analysts forecast that Aflac Incorporated will post 6.41 EPS for the current year.

Insider Transactions at Aflac

In related news, Director Arthur Reginald Collins sold 3,000 shares of the business’s stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total transaction of $239,190.00. Following the completion of the transaction, the director now owns 5,592 shares in the company, valued at approximately $445,850.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Masatoshi Koide sold 30,493 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $79.91, for a total transaction of $2,436,695.63. Following the completion of the transaction, the director now owns 86,090 shares in the company, valued at approximately $6,879,451.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Arthur Reginald Collins sold 3,000 shares of the business’s stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total value of $239,190.00. Following the transaction, the director now owns 5,592 shares of the company’s stock, valued at approximately $445,850.16. The disclosure for this sale can be found here. In the last quarter, insiders sold 46,493 shares of company stock worth $3,765,706. 0.80% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

AFL has been the topic of a number of recent analyst reports. Keefe, Bruyette & Woods raised their price target on shares of Aflac from $83.00 to $87.00 and gave the company a “market perform” rating in a report on Wednesday, April 10th. The Goldman Sachs Group raised their price target on shares of Aflac from $61.00 to $75.00 and gave the stock a “sell” rating in a research report on Tuesday, January 9th. Wells Fargo & Company cut their target price on shares of Aflac from $83.00 to $81.00 and set an “equal weight” rating for the company in a report on Thursday, April 11th. Raymond James lifted their target price on shares of Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a report on Friday, February 2nd. Finally, Morgan Stanley lifted their price target on shares of Aflac from $80.00 to $84.00 and gave the company an “equal weight” rating in a research note on Monday, April 15th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Aflac currently has an average rating of “Hold” and a consensus target price of $82.15.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.